Covaxin supply suspension by WHO not to impact travel by people: MEA

 WHO suspending the supply of Covaxin through UN procurement agencies over “process and facility upgrade” requirements will not have an impact on travel

World Health Organization (WHO) suspending the supply of Covaxin through UN procurement agencies over “process and facility upgrade” requirements will not have an impact on travel by those who have taken the COVID vaccine, Ministry of External Affairs said on Thursday.

Answering a query about the impact on people travelling abroad due to the present suspension of Covaxin supplies, MEA spokesperson Arindam Bagchi said that in terms of their travel, the vaccine continues to be recognized under the emergency use listing of WHO and various countries have already accepted it.

“I think there has been a statement issued by Bharat Biotech as well as from WHO, both of which are very clear in emphasizing that the vaccine is safe, its effective. Its efficacy is not in question,” Bagchi said at the regular media briefing. “There is something about process issues that are being worked out between the company and WHO. You will have to ask them about the details,” he added.